Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
NEJM Interview: Lawrence Casalino on qualities of corporate organizations that could affect physicians’ intrinsic motivation and the quality of the care they provide.
12 mins; April 01, 2026
NEJM Interview: Douglas Opel on the importance of clinician–parent communication amid changes to the childhood vaccine schedule.
9 mins; March 25, 2026
NEJM Interview: Abbas Hassan on the gap between the services that residents and fellows provide and the revenue that hospitals can capture.
8 mins; March 11, 2026
NEJM Interview: Ruqaiijah Yearby on recent trends in health care markets and their implications for health equity.
6 mins; March 04, 2026
NEJM Interview: Bruce Chabner on recent FDA statements regarding potential uses for leucovorin.
6 mins; February 25, 2026
NEJM Interview: Sonja Rasmussen on the 2025–2026 influenza season, including factors contributing to the intensity of influenza activity.
5 mins; February 18, 2026
NEJM Interview: Carmel Shachar on the opportunities and risks presented by the Rural Health Transformation Program.
7 mins; February 11, 2026
NEJM Interview: Leemore Dafny on the implications of corporatization of the U.S. health insurance industry.
11 mins; February 04, 2026
NEJM Interview: Robert Kocher on strategies for improving blood-pressure control in the United States.
6 mins; January 28, 2026
NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism.
14 mins; January 21, 2026
NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency.
12 mins; January 14, 2026
NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States.
10 mins; January 07, 2026
NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services.
9 mins; December 31, 2025
NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend.
7 mins; December 17, 2025
NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.
9 mins; December 10, 2025
NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy.
14 mins; December 03, 2025
NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications.
11 mins; November 26, 2025
NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine.
10 mins; November 19, 2025
NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders.
12 mins; November 12, 2025
NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization.
7 mins; November 05, 2025
NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease.
9 mins; October 22, 2025
NEJM Interview: Michael Liu on a new model that will expand the use of prior authorization in traditional Medicare.
9 mins; October 15, 2025
NEJM Interview: Andrew Gabrielson on cuts to the U.S. research agency charged with safeguarding workers’ health.
5 mins; October 08, 2025
NEJM Interview: Steven Lipstein on the drivers and the benefits of mergers and consolidation, from the perspective of a health care system leader.
11 mins; October 01, 2025
NEJM Interview: Nancy Krieger on the effects of structural racism on health and health care and the conflation of research on health equity with DEI work.
10 mins; September 24, 2025
NEJM Interview: John Ayanian on opportunities to study the health and economic effects of Medicaid work requirements and to mitigate their adverse consequences.
10 mins; September 17, 2025
NEJM Interview: Darshali Vyas on campaigns to remove race from clinical algorithms.
10 mins; September 10, 2025
NEJM Interview: Amanda Janitz on a navigation program aimed at improving cancer outcomes for American Indian and Alaska Native patients.
6 mins; September 10, 2025
NEJM Interview: Amitabh Chandra on why corporatization occurs in health care, when it can succeed, and why it can go wrong.
13 mins; September 03, 2025
NEJM Interview: Nicholas Bagley on the Supreme Court’s decision in a case with implications for coverage of preventive services.
13 mins; August 20, 2025
NEJM Interview: Tom Frieden on the role of the CDC and current threats to the U.S. public health infrastructure.
10 mins; August 13, 2025
NEJM Interview: Nancy Tomes on the century-long transition to a corporate business model in U.S. health care.
17 mins; August 06, 2025
NEJM Interview: Rohan Khazanchi on the gradual but incomplete shift to race-free equations for interpreting pulmonary function tests.
30 mins; July 30, 2025
NEJM Interview: Jason Schwartz on changes to the Advisory Committee on Immunization Practices and approaches to sustaining U.S. vaccination efforts.
8 mins; July 30, 2025
NEJM Interview: Katie Watson on the interaction of abortion laws with advance-directive and end-of-life laws.
12 mins; July 23, 2025
NEJM Interview: Peter Marks on the disruption of traditional approaches to establishing Covid-19 vaccine policy in the United States.
9 mins; July 16, 2025
NEJM Interview: Patricia Mae Santos on the effects of U.S. anti-immigrant policies on immigrant health care workers and their patients.
11 mins; July 09, 2025
NEJM Interview: Erin Fuse Brown on the manifestations and effects of corporatization in health care.
11 mins; July 02, 2025
NEJM Interview: Dariush Mozaffarian on the health harms of ultraprocessed foods and related policy actions.
17 mins; June 25, 2025
NEJM Interview: I. Glenn Cohen on the professional implications of the use of artificial-intelligence–based monitoring systems in medicine.
7 mins; June 18, 2025
NEJM Interview: Amanda Kallen on the history of women’s health research and recent actions that are jeopardizing progress in women’s health.
12 mins; June 11, 2025
NEJM Interview: David Jones on the disparate historical approaches to anemia diagnosis and their lessons for physicians.
40 mins; June 04, 2025
NEJM Interview: Amar Kelkar on NIH indirect-cost coverage and U.S. medical research.
7 mins; June 04, 2025
NEJM Interview: Zirui Song on the rise of concierge and direct primary care practices in the United States.
13 mins; May 28, 2025
NEJM Interview: Alice Chen on responding to the U.S. administration’s threats to health and physicians’ values and maintaining hope in difficult times.
11 mins; May 14, 2025
NEJM Interview: Christopher Duggan on the effects of ending U.S. foreign-assistance and global health programs.
7 mins; May 07, 2025
NEJM Interview: Arthur Robin Williams on alcohol consumption in the United States and the effects of alcohol taxes.
9 mins; April 30, 2025
NEJM Interview: Lauren Jatt on the efficacy of twice-yearly lenacapavir for preexposure prophylaxis and its implications for the development of an HIV vaccine.
8 mins; April 23, 2025
NEJM Outbreaks Updates — H5N1 in Indiana
20 mins; April 22, 2025
NEJM Interview: Patricia Zettler on a proposed FDA rule on nicotine yields and potential challenges moving forward.
8 mins; April 16, 2025
NEJM Interview: John Patrick Co on a stipend program designed to address cost-of-living concerns for residency applicants.
5 mins; April 09, 2025
NEJM Interview: Rochelle Walensky on the increased workload and emotional and financial burden associated with applying to medical school.
13 mins; March 28, 2025
NEJM Interview: Erin Fuse Brown on telehealth arrangements that have prompted concerns about inappropriate prescribing and unnecessary spending.
10 mins; March 26, 2025
NEJM Interview: Alex Keuroghlian on responding to policy threats to protections for transgender and nonbinary people.
9 mins; March 12, 2025
NEJM Outbreaks Update — H5N1: A View from the States
34 mins; March 11, 2025
NEJM Interview: Sara Gerke on the potential for genetic data and other personal information to be included in business transactions in the United States.
7 mins; March 05, 2025
NEJM Outbreaks Update — H5N1
19 mins; March 04, 2025
NEJM Interview: John Kelly on shifts in approaches for addressing substance use disorder.
10 mins; February 26, 2025
NEJM Interview: Peter Ubel on strategies for protecting patients from high out-of-pocket costs for drugs with questionable benefits.
6 mins; February 19, 2025
NEJM Interview: Yashaswini Singh on the expansion of private equity investments in health care and actions to safeguard patient interests in various countries.
11 mins; February 12, 2025
NEJM Interview: Joseph Ross on the newly implemented Cell and Gene Therapy Access Model.
8 mins; February 05, 2025
NEJM Interview: Daniel Aaron on a Supreme Court case about e-cigarettes that could have implications for the FDA’s authority and for public health.
9 mins; January 29, 2025
NEJM Interview: Craig Spencer on the need for action to address persistent inequities in global health.
17 mins; January 22, 2025
NEJM Interview: Carmel Shachar on modernizing labor laws and strike regulations to support physicians, patients, and hospitals.
9 mins; January 15, 2025
NEJM Interview: David Velasquez on care for older, low-income adults who can’t enroll in Medicare or Medicaid because they’re undocumented immigrants.
11 mins; January 08, 2025
NEJM Interview: Joey Mattingly on providing widespread access to HCV treatment at the lowest possible price.
12 mins; January 01, 2025
NEJM Interview: Lauren Schiff on the need for improved training and increased comfort in treating autistic people.
12 mins; December 18, 2024
NEJM Interview: Bindu Kanapuru on the FDA’s new expedited withdrawal procedure for accelerated approvals.
9 mins; December 11, 2024
NEJM Interview: Karen Joynt Maddox on the Transforming Episode Accountability Model recently announced by CMS.
11 mins; December 04, 2024
NEJM Interview: Andrew Hantel on a source of discrimination against some patients in cancer research and care practices.
13 mins; November 27, 2024
NEJM Interview: Benjamin Rome on the results of the initial round of drug-price negotiation under the Inflation Reduction Act.
9 mins; November 20, 2024
NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
4 mins; November 17, 2024
NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction
3 mins; November 16, 2024
NEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
4 mins; November 15, 2024
NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia
2 mins; November 15, 2024
NEJM at AHA — CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
3 mins; November 15, 2024
NEJM at AHA — Left Atrial Appendage Closure after Ablation for Atrial Fibrillation
4 mins; November 15, 2024
NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes
3 mins; November 15, 2024
NEJM Interview: Heather Hsu on an institutional conference series that provides opportunities for addressing the adverse effects of bias and medical racism.
8 mins; November 13, 2024
The Marburg Virus Outbreak in Rwanda
33 mins; November 06, 2024
NEJM Interview: Vincent Guilamo-Ramos on the need to rethink the response to HIV in Latino communities.
7 mins; November 06, 2024
NEJM Interview: Liam McCoy on concerns about the implementation of large language models in note writing and related clinical tasks.
13 mins; October 30, 2024
NEJM Interview: Mark Wicclair on approaches to protecting both physicians’ conscience and patients’ health.
8 mins; October 23, 2024
NEJM Interview: Jose Figueroa on the potential effects of the results of the 2024 elections on health care access, affordability, and equity.
21 mins; October 16, 2024
NEJM Interview: Jean Nachega on the mpox Public Health Emergency of International Concern.
9 mins; October 09, 2024
NEJM Interview: Jonathan Oberlander on the implications of the 2024 U.S. elections for health care reform.
8 mins; October 02, 2024
NEJM Interview: Abigail Cutler on providing training in abortion care to Ob/Gyn residents amid legal restrictions.
10 mins; September 25, 2024
NEJM Interview: Charles Weijer on the potential benefits and ethical challenges associated with pragmatic and cluster RCTs.
11 mins; September 18, 2024
NEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine Tumors
2 mins; September 15, 2024
NEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma
2 mins; September 15, 2024
NEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
3 mins; September 14, 2024
NEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
3 mins; September 14, 2024
NEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
3 mins; September 14, 2024
NEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
3 mins; September 14, 2024
NEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast Cancer
3 mins; September 14, 2024
NEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric Cancer
2 mins; September 13, 2024
NEJM at ESMO — Ponsegromab in Cancer Cachexia
2 mins; September 13, 2024
NEJM at ESMO — Pembrolizumab in HER2+ Gastric Cancer
2 mins; September 13, 2024
NEJM Interview: Benjamin Chrisinger on proposed changes to the Supplemental Nutrition Assistance Program and other options for promoting improved health.
9 mins; September 11, 2024
NEJM Interview: Erin Fuse Brown on the potential implications of recent Supreme Court decisions for health law and policy.
